Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Salmonella</i> Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses.

Science immunology·2021
Same author

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.

Nature communications·2017
Same author

Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.

Clinical immunology (Orlando, Fla.)·2017
Same author

Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015
Same author

Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality.

Proteome science·2014
Same author

Single-step capture and sequencing of natural DNA for detection of BRCA1 mutations.

Genome research·2011

Related Experiment Video

Updated: Mar 13, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.4K

DeepFRAG: a method for cancer detection based on DNA fragmentomics and deep learning.

Andrey Koch1, Eldar Giladi1

  • 1Laboratory Corporation of America Holdings (Labcorp), Burlington, NC 27215, United States.

Bioinformatics Advances
|March 12, 2026
PubMed
Summary

DeepFRAG, a novel deep learning method, analyzes cell-free DNA fragment sizes for accurate and cost-effective cancer screening. This noninvasive approach shows high sensitivity and specificity, improving patient outcomes.

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.3K
Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

13.7K

Related Experiment Videos

Last Updated: Mar 13, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.4K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.3K
Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
10:16

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines

Published on: October 8, 2015

13.7K

Area of Science:

  • Oncology
  • Bioinformatics
  • Artificial Intelligence

Background:

  • Liquid biopsy analyzing cell-free DNA (cfDNA) is crucial in cancer screening.
  • Mutation-based diagnostics are sensitive but costly; cfDNA fragment size analysis offers a cost-effective alternative.

Purpose of the Study:

  • To introduce DeepFRAG, a deep learning method for cancer detection using cfDNA fragment size distribution.
  • To evaluate DeepFRAG's accuracy and effectiveness in diverse cancer types.

Main Methods:

  • Deep learning analysis of cfDNA fragment size distribution profiles utilizing wavelet transform.
  • Development of a novel data augmentation technique for whole genome sequencing (WGS) fragment size data.
  • Validation on two independent cohorts (73 cancer patients, 80 healthy individuals).

Main Results:

  • DeepFRAG achieved a median AUROC of 0.974.
  • The method demonstrated high sensitivity (96.1%) and specificity (98.8%).
  • Effective in detecting multiple major cancer types (breast, colorectal, pancreatic, lung, liver).

Conclusions:

  • DeepFRAG offers a highly accurate, cost-effective, and robust noninvasive cancer detection method.
  • This advancement expands options for early cancer screening and improved patient outcomes.
  • Source code and data are publicly available for further research and application.